Sort
25,944 grants matching “neurodegeneration”
Altering immune tolerance in Alzheimer disease
$199,875Ken-Ichiro Fukuchi · University Of Illinois At Chicago · R21 · FY2019 · AG
Role of extracellular vesicles in the high-fat diet-induced risk of Alzheimer disease
$199,875Ken-Ichiro Fukuchi · University Of Illinois At Chicago · R21 · FY2017 · AG
Deciphering the molecular landscape of frontotemporal lobar degeneration: A network-based proteomic approach
$199,830Rowan Saloner · University Of California, San Francisco · K23 · FY2025 · AG
Astrocyte activation by small-molecule ADORA3 agonists: a novel therapy for Alzheimer's disease
$199,830James D Lechleiter · Astrocyte Pharmaceuticals, Inc. · R41 · FY2018 · AG
FG-nucleoporins and nuclear transport disruption in C9ORF72-ALS/FTD
$199,800Lindsey Renae Hayes · Johns Hopkins University · K08 · FY2021 · NS
FG-nucleoporins and nuclear transport disruption in C9ORF72-ALS/FTD
$199,800Lindsey Renae Hayes · Johns Hopkins University · K08 · FY2017 · NS
FG-nucleoporins and nuclear transport disruption in C9ORF72-ALS/FTD
$199,800Lindsey Renae Hayes · Johns Hopkins University · K08 · FY2019 · NS
FG-nucleoporins and nuclear transport disruption in C9ORF72-ALS/FTD
$199,800Lindsey Renae Hayes · Johns Hopkins University · K08 · FY2018 · NS
FG-nucleoporins and nuclear transport disruption in C9ORF72-ALS/FTD
$199,800Lindsey Renae Hayes · Johns Hopkins University · K08 · FY2020 · NS
Defining the genetic contribution of glia in Parkinson's disease pathogenesis
$199,800Abby Lauren Olsen · Brigham And Women'S Hospital · K08 · FY2018 · NS
A novel enzymatic mechanism for removing neurotoxic aldehydes after rodent spinal cord injury
$199,798Riyi Shi · Purdue University · R21 · FY2019 · NS
Role of microRNAs as modulators of neuroinflammation in Alzheimer disease
$199,750Ken-Ichiro Fukuchi · University Of Illinois At Chicago · R21 · FY2015 · AG
BIOENERGETICS
$199,651David Nicholls · Buck Institute For Research On Aging · P01 · FY2007 · AG
Anchored Antioxidants to Provide Increased Protective Effect
$199,500William A. Garland · Tosk, Inc. · R43 · FY2010 · HL
Characterization of Dentate Mossy Cell-restricted Genetic Manipulation Mice
$199,441Kazutoshi Nakazawa · National Institute Of Mental Health · ZIA · FY2010 · MH
Defining the genetic contribution of glia in Parkinson's disease pathogenesis
$199,422Abby Lauren Olsen · Brigham And Women'S Hospital · K08 · FY2019 · NS
Defining the genetic contribution of glia in Parkinson's disease pathogenesis
$199,422Abby Lauren Olsen · University Of Pittsburgh At Pittsburgh · K08 · FY2022 · NS
Defining the genetic contribution of glia in Parkinson's disease pathogenesis
$199,422Abby Lauren Olsen · Brigham And Women'S Hospital · K08 · FY2020 · NS
Molecular Mechanisms of Diabetic Retinal Ganglion Cell Dysfunction and Neurovascular Crosstalk in Early Diabetic Retinopathy
$199,413Mira Menon Sachdeva · Johns Hopkins University · K08 · FY2023 · EY
Molecular Mechanisms of Diabetic Retinal Ganglion Cell Dysfunction and Neurovascular Crosstalk in Early Diabetic Retinopathy
$199,413Mira Menon Sachdeva · Johns Hopkins University · K08 · FY2020 · EY
Molecular Mechanisms of Diabetic Retinal Ganglion Cell Dysfunction and Neurovascular Crosstalk in Early Diabetic Retinopathy
$199,413Mira Menon Sachdeva · Johns Hopkins University · K08 · FY2021 · EY
Molecular Mechanisms of Diabetic Retinal Ganglion Cell Dysfunction and Neurovascular Crosstalk in Early Diabetic Retinopathy
$199,413Mira Menon Sachdeva · Johns Hopkins University · K08 · FY2022 · EY
Molecular Mechanisms of Diabetic Retinal Ganglion Cell Dysfunction and Neurovascular Crosstalk in Early Diabetic Retinopathy
$199,413Mira Menon Sachdeva · Johns Hopkins University · K08 · FY2019 · EY
Cholesterol Biomarkers and Oxysterols in Multiple Sclerosis Progression
$199,375Murali Ramanathan · State University Of New York At Buffalo · R21 · FY2017 · NS
RETINAL CELL MODEL FOR BATTEN DISEASE
$199,375University Of Rochester · R21 · FY2002 · NS